BRAINLIFE.ORG
|
|
|
|
|
Topics
|
|
Glioblastoma
| Treatment | Targeted therapy | Bevacizumab | Efficacy
|
|
|
|
|
|
Home
> Publications
> Topics
> Glioblastoma
>
Treatment
>
Targeted
therapy >
Bevacizumab
>
Efficacy
|
|
|
|
|
|
Zhang JF, Okai B, Iovoli A,
Goulenko V, Attwood K, Lim J, Hess RM, Abad AP, Prasad D,
Fenstermaker RA.
Bevacizumab
and gamma knife radiosurgery for first-recurrence glioblastoma.
J
Neurooncol. 2024
Jan 4. doi:
10.1007/s11060-023-04524-y. PMID:
38175460. Observational study. ˍ
|
|
|
|
*Sferruzza G, Malcangi M, Bosco L, Finocchiaro G.
Reassessing
the efficacy of bevacizumab in newly diagnosed glioblastoma: A
systematic review and external pseudodata-based
analysis.
Neurooncol
Adv. 2024 Jan 22;6(1):vdad174. doi:
10.1093/noajnl/vdad174. PMID:
38390032. Review. ˍ
|
|
|
|
Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P,
Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P.
Stereotactic radiosurgery versus
combined stereotactic radiosurgery and bevacizumab for recurrent
glioblastoma; a systematic review and meta-analysis of survival.
Neurosurg
Rev. 2024 Jul 13;47(1):323. doi:
10.1007/s10143-024-02585-9. PMID:
39002028. Review; Meta-analysis˰
ˍ
|
|
|
|
Lee Y, Lee E, Roh TH, Kim SH.
Bevacizumab
Alone Versus Bevacizumab Plus Irinotecan in Patients With
Recurrent Glioblastoma: A Nationwide Population-Based Study.
J
Korean Med Sci. 2024 Jul 29;39(34):e244. doi:
10.3346/jkms.2024.39.e244. PMID:
39228184. Observational study. ˍ
|
|
|
|
Habibi MA, Shad N, Mirjnani MS, Fasihi S, Sadeghi S, Karami S,
Ahmadvand MH, Delbari P, Zare AH, Zare AH, Alavi SAN.
Is
add-on Bevacizumab therapy to Temozolomide and radiotherapy
associated with clinical utility for newly diagnosed Glioblastoma?
A systematic review and meta-analysis.
Neurosurg
Rev. 2024 Aug 20;47(1):445. doi:
10.1007/s10143-024-02667-8. PMID:
39162874. Review; Meta-analysis˰
ˍ
|
|
|
|
*Yang F, Wang L, Zhao W, Wang S, Li J, Sun A, Wang M, Wang Z, Chen
Z, Heng X.
A Systematic Review and
Meta-Analysis on the Effectiveness of Radiotherapy and
Temozolomide Treatment With or
Without Bevacizumab in Patients With Glioblastoma
Multiforme.
Neurol
India. 2024 Aug 31;72(4):700-707. doi:
10.4103/neurol-india.Neurol-India-D-23-00346. PMID:
39216020. Review; Meta-Analysis. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|